Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
AstraZeneca
Johnson and Johnson
Mallinckrodt
McKinsey

Last Updated: October 16, 2019

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: INSULIN GLARGINE RECOMBINANT

See Plans and Pricing

« Back to Dashboard

INSULIN GLARGINE RECOMBINANT

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Sanofi Aventis Us LANTUS insulin glargine recombinant INJECTABLE;INJECTION 021081 NDA sanofi-aventis U.S. LLC 0088-2219-00 1 SYRINGE in 1 CARTON (0088-2219-00) > 3 mL in 1 SYRINGE
Sanofi Aventis Us LANTUS insulin glargine recombinant INJECTABLE;INJECTION 021081 NDA sanofi-aventis U.S. LLC 0088-2219-05 5 SYRINGE in 1 CARTON (0088-2219-05) > 3 mL in 1 SYRINGE
Sanofi Aventis Us LANTUS insulin glargine recombinant INJECTABLE;INJECTION 021081 NDA sanofi-aventis U.S. LLC 0088-2220-33 1 VIAL, GLASS in 1 CARTON (0088-2220-33) > 10 mL in 1 VIAL, GLASS
Sanofi Aventis Us LANTUS insulin glargine recombinant INJECTABLE;INJECTION 021081 NDA sanofi-aventis U.S. LLC 0088-2220-34 1 VIAL, GLASS in 1 CARTON (0088-2220-34) > 10 mL in 1 VIAL, GLASS
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Merck
Johnson and Johnson
Mallinckrodt
Harvard Business School